CN Stock MarketDetailed Quotes

603233 DaShenLin Pharmaceutical Group

Watchlist
  • 12.40
  • -0.21-1.67%
Market Closed Jul 29 15:00 CST
14.12BMarket Cap13.22P/E (TTM)

DaShenLin Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
13.54%6.75B
15.45%24.53B
19.61%17.72B
23.37%11.99B
27.16%5.95B
26.78%21.25B
19.93%14.82B
20.68%9.72B
15.22%4.68B
14.92%16.76B
Operating revenue
13.54%6.75B
15.45%24.53B
19.61%17.72B
23.37%11.99B
27.16%5.95B
26.78%21.25B
19.93%14.82B
20.68%9.72B
15.22%4.68B
14.92%16.76B
Other operating revenue
----
28.29%599.94M
----
2.65%291.18M
----
-0.02%467.67M
----
17.76%283.66M
----
45.89%467.77M
Total operating cost
17.97%6.2B
15.36%22.9B
18.49%16.14B
22.12%10.77B
25.80%5.25B
25.34%19.85B
19.64%13.62B
20.85%8.82B
14.83%4.17B
19.97%15.84B
Operating cost
18.47%4.36B
18.97%15.72B
22.96%11.16B
27.64%7.5B
34.54%3.68B
27.51%13.22B
18.91%9.07B
19.82%5.88B
11.11%2.73B
15.52%10.37B
Operating tax surcharges
23.39%23.39M
18.42%94.68M
12.57%60.43M
14.42%40.66M
9.72%18.96M
17.36%79.95M
14.60%53.68M
18.20%35.54M
18.40%17.28M
13.47%68.12M
Operating expense
17.79%1.47B
8.98%5.62B
9.15%3.9B
11.28%2.58B
9.66%1.25B
20.95%5.16B
19.86%3.58B
21.63%2.32B
20.98%1.14B
22.91%4.27B
Administration expense
13.08%281.72M
6.74%1.18B
12.83%834.92M
12.49%526.93M
13.20%249.14M
20.55%1.11B
22.35%739.96M
23.96%468.41M
18.67%220.08M
31.21%920.61M
Financial expense
16.70%51.21M
-8.41%190.15M
4.45%151.16M
-3.96%97.29M
-24.07%43.88M
21.97%207.61M
29.09%144.73M
40.49%101.29M
73.95%57.79M
1,639.96%170.21M
-Interest expense (Financial expense)
3.31%62.25M
3.14%239.26M
1.33%181.73M
-0.52%120.2M
4.12%60.25M
9.40%231.97M
18.26%179.35M
30.84%120.83M
15.63%57.87M
1,744.27%212.04M
-Interest Income (Financial expense)
2.72%-18.99M
-35.06%-85.19M
-39.31%-60.43M
-72.68%-42.14M
-100.26%-19.52M
7.61%-63.08M
29.01%-43.38M
43.85%-24.4M
59.38%-9.75M
-37.83%-68.27M
Research and development
-12.48%12.8M
8.81%80.93M
0.94%36.04M
32.20%24.43M
69.01%14.62M
66.74%74.38M
277.15%35.7M
178.12%18.48M
348.34%8.65M
848.99%44.61M
Credit Impairment Loss
43.13%-1.29M
11.13%-29.69M
-85.66%-8.4M
38.01%-6.6M
-38.84%-2.28M
-135.18%-33.4M
38.98%-4.53M
-50.84%-10.64M
7.35%-1.64M
-66.61%-14.2M
Asset Impairment Loss
90.54%-2.19M
-765.79%-77.21M
-204.20%-20.27M
-210.62%-17.21M
-7,521.88%-23.11M
54.42%-8.92M
15.82%-6.66M
0.54%-5.54M
27.67%-303.15K
21.00%-19.57M
Other net revenue
226.99%14.18M
-109.76%-2.06M
-17.58%24.33M
-56.25%14.18M
-13.40%-11.17M
-81.85%21.16M
-74.14%29.51M
-68.51%32.42M
-129.74%-9.85M
80.10%116.61M
Fair value change income
-91.08%-3.55M
123.43%4.38M
126.72%8.31M
121.53%3.13M
92.97%-1.86M
-154.11%-18.71M
-150.87%-31.1M
-119.56%-14.54M
-5,117.66%-26.42M
345.37%34.57M
Invest income
----
12.84%6.56M
27.34%3.84M
238.40%3.26M
-134.52%-122.01K
-38.33%5.81M
-78.62%3.02M
-134.33%-2.36M
-94.08%353.44K
-48.09%9.43M
-Including: Investment income associates
----
-210.87%-142.5K
-219.28%-111.79K
-355.29%-111.79K
----
65.21%-45.84K
70.72%-35.01K
68.17%-24.55K
----
80.97%-131.75K
Asset deal income
-468.63%-1.8M
-81.69%3.43M
-292.57%-2.87M
-9.78%1.22M
-60.70%488.11K
232.49%18.73M
327.54%1.49M
15.21%1.35M
334.01%1.24M
322.54%5.63M
Other revenue
46.48%23.01M
56.93%90.46M
-35.03%43.72M
-52.63%30.39M
-7.17%15.71M
-42.78%57.64M
24.88%67.29M
92.96%64.14M
-42.32%16.92M
34.96%100.74M
Operating profit
-16.55%570.86M
14.85%1.63B
31.16%1.6B
32.37%1.23B
38.93%684.09M
36.54%1.42B
13.06%1.22B
8.60%931.34M
7.81%492.39M
-28.14%1.04B
Add:Non operating Income
-58.18%2.51M
9.03%26.28M
-37.18%10.12M
-54.76%6.33M
113.91%6.01M
112.20%24.1M
126.19%16.11M
210.68%14M
14.93%2.81M
65.57%11.36M
Less:Non operating expense
-87.22%1.37M
1.12%30.34M
80.17%24.21M
54.88%12.48M
694.18%10.74M
275.98%30M
24.75%13.43M
-4.42%8.06M
-12.89%1.35M
-5.14%7.98M
Total profit
-15.80%572M
15.05%1.63B
29.73%1.59B
30.87%1.23B
37.56%679.36M
35.54%1.41B
13.69%1.23B
9.80%937.28M
7.91%493.85M
-27.83%1.04B
Less:Income tax cost
-23.72%118.31M
18.32%397.12M
22.25%367.72M
21.48%272.66M
40.56%155.09M
40.12%335.62M
20.57%300.8M
13.83%224.45M
0.63%110.34M
-34.09%239.52M
Add:Adjusted items effecting net profit
----
----
----
---0.01
----
----
----
----
---0.01
----
Net profit
-13.46%453.69M
14.03%1.23B
32.16%1.22B
33.83%953.98M
36.70%524.26M
34.17%1.08B
11.62%925.11M
8.59%712.83M
10.21%383.51M
-25.73%804.39M
Net profit from continuing operation
-13.46%453.69M
14.03%1.23B
32.16%1.22B
33.83%953.98M
36.70%524.26M
34.17%1.08B
11.62%925.11M
8.59%712.83M
10.21%383.51M
-25.73%804.39M
Less:Minority Profit
100.79%55.24M
47.33%64.16M
2,478.55%48.25M
2,793.63%36.55M
3,964.83%27.51M
230.83%43.55M
-82.18%1.87M
-112.54%-1.36M
-109.57%-711.82K
-36.83%13.16M
Net profit of parent company owners
-19.79%398.45M
12.63%1.17B
27.20%1.17B
28.46%917.43M
29.29%496.75M
30.90%1.04B
12.82%923.24M
10.62%714.19M
12.82%384.22M
-25.51%791.23M
Earning per share
Basic earning per share
-32.69%0.35
13.19%1.03
27.16%1.03
8.00%0.81
6.12%0.52
8.33%0.91
-5.81%0.81
10.29%0.75
13.95%0.49
-37.78%0.84
Diluted earning per share
-32.69%0.35
13.19%1.03
27.16%1.03
8.00%0.81
6.12%0.52
8.33%0.91
-5.81%0.81
10.29%0.75
13.95%0.49
-37.78%0.84
Other composite income
Total composite income
-13.46%453.69M
14.03%1.23B
32.16%1.22B
33.83%953.98M
36.70%524.26M
34.17%1.08B
11.62%925.11M
8.59%712.83M
10.21%383.51M
-25.73%804.39M
Total composite income of parent company owners
-19.79%398.45M
12.63%1.17B
27.20%1.17B
28.46%917.43M
29.29%496.75M
30.90%1.04B
12.82%923.24M
10.62%714.19M
12.82%384.22M
-25.51%791.23M
Total composite income of minority owners
100.79%55.24M
47.33%64.16M
2,478.55%48.25M
2,793.63%36.55M
3,964.83%27.51M
230.83%43.55M
-82.18%1.87M
-112.54%-1.36M
-109.57%-711.82K
-36.83%13.16M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 13.54%6.75B15.45%24.53B19.61%17.72B23.37%11.99B27.16%5.95B26.78%21.25B19.93%14.82B20.68%9.72B15.22%4.68B14.92%16.76B
Operating revenue 13.54%6.75B15.45%24.53B19.61%17.72B23.37%11.99B27.16%5.95B26.78%21.25B19.93%14.82B20.68%9.72B15.22%4.68B14.92%16.76B
Other operating revenue ----28.29%599.94M----2.65%291.18M-----0.02%467.67M----17.76%283.66M----45.89%467.77M
Total operating cost 17.97%6.2B15.36%22.9B18.49%16.14B22.12%10.77B25.80%5.25B25.34%19.85B19.64%13.62B20.85%8.82B14.83%4.17B19.97%15.84B
Operating cost 18.47%4.36B18.97%15.72B22.96%11.16B27.64%7.5B34.54%3.68B27.51%13.22B18.91%9.07B19.82%5.88B11.11%2.73B15.52%10.37B
Operating tax surcharges 23.39%23.39M18.42%94.68M12.57%60.43M14.42%40.66M9.72%18.96M17.36%79.95M14.60%53.68M18.20%35.54M18.40%17.28M13.47%68.12M
Operating expense 17.79%1.47B8.98%5.62B9.15%3.9B11.28%2.58B9.66%1.25B20.95%5.16B19.86%3.58B21.63%2.32B20.98%1.14B22.91%4.27B
Administration expense 13.08%281.72M6.74%1.18B12.83%834.92M12.49%526.93M13.20%249.14M20.55%1.11B22.35%739.96M23.96%468.41M18.67%220.08M31.21%920.61M
Financial expense 16.70%51.21M-8.41%190.15M4.45%151.16M-3.96%97.29M-24.07%43.88M21.97%207.61M29.09%144.73M40.49%101.29M73.95%57.79M1,639.96%170.21M
-Interest expense (Financial expense) 3.31%62.25M3.14%239.26M1.33%181.73M-0.52%120.2M4.12%60.25M9.40%231.97M18.26%179.35M30.84%120.83M15.63%57.87M1,744.27%212.04M
-Interest Income (Financial expense) 2.72%-18.99M-35.06%-85.19M-39.31%-60.43M-72.68%-42.14M-100.26%-19.52M7.61%-63.08M29.01%-43.38M43.85%-24.4M59.38%-9.75M-37.83%-68.27M
Research and development -12.48%12.8M8.81%80.93M0.94%36.04M32.20%24.43M69.01%14.62M66.74%74.38M277.15%35.7M178.12%18.48M348.34%8.65M848.99%44.61M
Credit Impairment Loss 43.13%-1.29M11.13%-29.69M-85.66%-8.4M38.01%-6.6M-38.84%-2.28M-135.18%-33.4M38.98%-4.53M-50.84%-10.64M7.35%-1.64M-66.61%-14.2M
Asset Impairment Loss 90.54%-2.19M-765.79%-77.21M-204.20%-20.27M-210.62%-17.21M-7,521.88%-23.11M54.42%-8.92M15.82%-6.66M0.54%-5.54M27.67%-303.15K21.00%-19.57M
Other net revenue 226.99%14.18M-109.76%-2.06M-17.58%24.33M-56.25%14.18M-13.40%-11.17M-81.85%21.16M-74.14%29.51M-68.51%32.42M-129.74%-9.85M80.10%116.61M
Fair value change income -91.08%-3.55M123.43%4.38M126.72%8.31M121.53%3.13M92.97%-1.86M-154.11%-18.71M-150.87%-31.1M-119.56%-14.54M-5,117.66%-26.42M345.37%34.57M
Invest income ----12.84%6.56M27.34%3.84M238.40%3.26M-134.52%-122.01K-38.33%5.81M-78.62%3.02M-134.33%-2.36M-94.08%353.44K-48.09%9.43M
-Including: Investment income associates -----210.87%-142.5K-219.28%-111.79K-355.29%-111.79K----65.21%-45.84K70.72%-35.01K68.17%-24.55K----80.97%-131.75K
Asset deal income -468.63%-1.8M-81.69%3.43M-292.57%-2.87M-9.78%1.22M-60.70%488.11K232.49%18.73M327.54%1.49M15.21%1.35M334.01%1.24M322.54%5.63M
Other revenue 46.48%23.01M56.93%90.46M-35.03%43.72M-52.63%30.39M-7.17%15.71M-42.78%57.64M24.88%67.29M92.96%64.14M-42.32%16.92M34.96%100.74M
Operating profit -16.55%570.86M14.85%1.63B31.16%1.6B32.37%1.23B38.93%684.09M36.54%1.42B13.06%1.22B8.60%931.34M7.81%492.39M-28.14%1.04B
Add:Non operating Income -58.18%2.51M9.03%26.28M-37.18%10.12M-54.76%6.33M113.91%6.01M112.20%24.1M126.19%16.11M210.68%14M14.93%2.81M65.57%11.36M
Less:Non operating expense -87.22%1.37M1.12%30.34M80.17%24.21M54.88%12.48M694.18%10.74M275.98%30M24.75%13.43M-4.42%8.06M-12.89%1.35M-5.14%7.98M
Total profit -15.80%572M15.05%1.63B29.73%1.59B30.87%1.23B37.56%679.36M35.54%1.41B13.69%1.23B9.80%937.28M7.91%493.85M-27.83%1.04B
Less:Income tax cost -23.72%118.31M18.32%397.12M22.25%367.72M21.48%272.66M40.56%155.09M40.12%335.62M20.57%300.8M13.83%224.45M0.63%110.34M-34.09%239.52M
Add:Adjusted items effecting net profit ---------------0.01-------------------0.01----
Net profit -13.46%453.69M14.03%1.23B32.16%1.22B33.83%953.98M36.70%524.26M34.17%1.08B11.62%925.11M8.59%712.83M10.21%383.51M-25.73%804.39M
Net profit from continuing operation -13.46%453.69M14.03%1.23B32.16%1.22B33.83%953.98M36.70%524.26M34.17%1.08B11.62%925.11M8.59%712.83M10.21%383.51M-25.73%804.39M
Less:Minority Profit 100.79%55.24M47.33%64.16M2,478.55%48.25M2,793.63%36.55M3,964.83%27.51M230.83%43.55M-82.18%1.87M-112.54%-1.36M-109.57%-711.82K-36.83%13.16M
Net profit of parent company owners -19.79%398.45M12.63%1.17B27.20%1.17B28.46%917.43M29.29%496.75M30.90%1.04B12.82%923.24M10.62%714.19M12.82%384.22M-25.51%791.23M
Earning per share
Basic earning per share -32.69%0.3513.19%1.0327.16%1.038.00%0.816.12%0.528.33%0.91-5.81%0.8110.29%0.7513.95%0.49-37.78%0.84
Diluted earning per share -32.69%0.3513.19%1.0327.16%1.038.00%0.816.12%0.528.33%0.91-5.81%0.8110.29%0.7513.95%0.49-37.78%0.84
Other composite income
Total composite income -13.46%453.69M14.03%1.23B32.16%1.22B33.83%953.98M36.70%524.26M34.17%1.08B11.62%925.11M8.59%712.83M10.21%383.51M-25.73%804.39M
Total composite income of parent company owners -19.79%398.45M12.63%1.17B27.20%1.17B28.46%917.43M29.29%496.75M30.90%1.04B12.82%923.24M10.62%714.19M12.82%384.22M-25.51%791.23M
Total composite income of minority owners 100.79%55.24M47.33%64.16M2,478.55%48.25M2,793.63%36.55M3,964.83%27.51M230.83%43.55M-82.18%1.87M-112.54%-1.36M-109.57%-711.82K-36.83%13.16M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg